None listed
Conditions
Interventions
Dietary Supplement : Experimental: GS8210213(1,000mg/day), 12 weeks, twice a day, 2 capsule at a time
Control: Placebo (test object with no GS8210213 and same properties as test), 12 weeks, twice a
Sponsors
Univera
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Males and females aged 50 years over at the screening examination 2) Those with a total score of 13 or less on SARC-CalF 3) Those whose skeletal muscle mass measured by BIA Bioelectrical Impedance Analysis) is less than 100% of the standard 4)Individuals who have fully understood the detailed explanation of this human study, voluntarily decided to participate, and provided written consent to comply with the guidelines
Exclusion criteria
Exclusion criteria: 1) Patients with a clinically significant disease requiring treatment (i.e., severe cardiovascular system, endocrine system, neuropsychiatric system, musculoskeletal inflammation, gastrointestinal disease, inflammatory disease, blood and tumor disease, etc.) 2) Patients who take medicine or health functional food for myofunction within a month prior to the screening examination 3) Patients with a history of antipsychotic medication use within 2 months prior to the screening examination 4)Patients who have participated in other clinical trials within 3 months prior to the screening examination 5)Patients who are judged ineligible to participate in the trial by the principal investigator for other reasons, including laboratory test outcomes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Isokinetic muscular strength;Handgrip Strength;Muscle mass;Short Physical Performance; SPPB | — |
Secondary
| Measure | Time frame |
|---|---|
| composite score;Muscle-related hormones;Timed up and go; TUG;C-Reactive Protein;skeletal muscle index; SMI | — |
Countries
Korea, Republic of
Contacts
Public Contactsi yeon Lee
Jeonbuk National University Hospital
Outcome results
None listed